why choose us

First received: November 01, 2023

Clinical Trial: An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Sclerosis

Study Type: INTERVENTIONAL


Official Title: An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Brief Summary: CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics.One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo) components.DiNaMo components target key neural systems (including but not limited to systems related to sensory-, perceptual-, affective-, pain-, attention-, cognitive control, social- and self-processing) to optimally improve a participant's…

Read more